rs28942104
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_000271.5(NPC1):c.3107C>T(p.Thr1036Met) variant causes a missense change. The variant allele was found at a frequency of 0.000106 in 1,614,044 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T1036K) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000271.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NPC1 | NM_000271.5 | c.3107C>T | p.Thr1036Met | missense_variant | 21/25 | ENST00000269228.10 | NP_000262.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NPC1 | ENST00000269228.10 | c.3107C>T | p.Thr1036Met | missense_variant | 21/25 | 1 | NM_000271.5 | ENSP00000269228 | P1 | |
NPC1 | ENST00000591051.1 | c.2186C>T | p.Thr729Met | missense_variant | 14/18 | 2 | ENSP00000467636 | |||
NPC1 | ENST00000591075.1 | n.740C>T | non_coding_transcript_exon_variant | 3/3 | 4 | |||||
NPC1 | ENST00000591955.1 | n.450C>T | non_coding_transcript_exon_variant | 2/2 | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152184Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000278 AC: 7AN: 251438Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135898
GnomAD4 exome AF: 0.000115 AC: 168AN: 1461860Hom.: 0 Cov.: 32 AF XY: 0.000110 AC XY: 80AN XY: 727238
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152184Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74322
ClinVar
Submissions by phenotype
Niemann-Pick disease, type C1 Pathogenic:6
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Likely pathogenic, criteria provided, single submitter | literature only | Counsyl | Jul 18, 2014 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jul 11, 1997 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Genomics England Pilot Project, Genomics England | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | Oct 19, 2020 | Based on the classification scheme VCGS_Germline_v1.3.3, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with Niemann-Pick disease (MIM#257220). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0200 - Variant is predicted to result in a missense amino acid change from threonine to methionine. (I) 0251 - This variant is heterozygous. (I) 0304 - Variant is present in gnomAD <0.01 for a recessive condition (8 heterozygotes, 0 homozygote). (SP) 0309 - An alternative amino acid change at the same position has been observed in gnomAD (v2.1.1) (2 heterozygotes, 0 homozygotes). (I) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools or highly conserved with a major amino acid change. (SP) 0602 - Variant is located in a hotspot region or cluster of pathogenic variants within the Lumen cystein rich domain (PMID: 16126423, PMID: 32138288). (SP) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals with Niemann-Pick disease, type C1 (ClinVar, PMID:9211849, PMID:19744920, PMID:22676771, PMID:26666848, PMID:28222799). (SP) 1010 - Functional evidence for this variant is inconclusive; NPC1 protein from patient fibroblast cells (compound heterozygous for this variant and p.(Pro1007Ala)) were shown to be mis-folded and displayed diminished function (PMID: 23653225). (I) 0703 - Other missense variants (p.(Thr1036Lys); p.(Thr1036Ala)) comparable to the one identified in this case have moderate previous evidence for pathogenicity (PMID:16098014, PMID:32138288). (SP) 1205 - This variant has been shown to be maternally inherited in her son (reported by Invitae #RQ745246). (I) Legend: (SP) – Supporting pathogenic, (I) – Information, (SB) – Supporting benign - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 24, 2024 | This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 1036 of the NPC1 protein (p.Thr1036Met). This variant is present in population databases (rs28942104, gnomAD 0.006%). This missense change has been observed in individual(s) with Niemann-Pick Type C disease (PMID: 9211849, 12955717, 17160617, 26666848, 28222799; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 2958). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt NPC1 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects NPC1 function (PMID: 23593294). For these reasons, this variant has been classified as Pathogenic. - |
Niemann-Pick disease, type C Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Dec 04, 2017 | Variant summary: The NPC1 c.3107C>T (p.Thr1036Met) variant involves the alteration of a highly conserved nucleotide. 4/4 in silico tools used predict a damaging outcome for this variant. This variant was found in 8/277208 control chromosomes at a frequency of 0.000029, which does not exceed the estimated maximal expected allele frequency of a pathogenic NPC1 variant (0.0028). The variant was identified in multiple affected individuals homozygously or in compound heterozygosity with clinically and biochemically confirmed Niemann-Pick C1 disease and is classified as Pathogenic by multiple clinical diagnostic laboratories/reputable databases. Taken together, this variant is classified as Pathogenic. - |
not provided Uncertain:1
Uncertain significance, flagged submission | clinical testing | Eurofins Ntd Llc (ga) | Aug 14, 2014 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at